Seema Nath | Structural Biology | Editorial Board Member

Published on by Molecular Biologist

Dr. Seema Nath | Structural Biology | Editorial Board Member 

Research Scientist | University of Texas Health Science Center at San Antonio | United States

Seema Nath is an emerging multidisciplinary plant scientist whose research spans plant physiology, proteomics, lipidomics, food composition, and agricultural biotechnology. Her recent work, including contributions to Plant Physiology, investigates cytosolic- and membrane-localized pathways of oxidized indole-3-acetic acid formation and their regulatory role in developmental auxin transients, advancing understanding of hormone-mediated plant growth processes. She has also explored the structural and biochemical diversity of rubber particle membrane domains through integrated proteomic and targeted lipidomic analyses in guayule, contributing valuable insights into natural rubber biosynthesis. Beyond plant physiology, Seema has examined nutritional and chemical differences between aromatic and non-aromatic rice varieties from Brazil, highlighting how planting time influences bioactive compound profiles important for food quality and health value. Her work in phytopathology further includes investigating the roles of tzs and idi genes of Agrobacterium rhizogenes in adventitious root formation, offering implications for plant–microbe interactions and biotechnology applications. Collectively, Seema Nath’s research reflects strong expertise in molecular plant biology, crop quality assessment, and applied agricultural sciences, with contributions that support advances in sustainable crop production and plant developmental biology.

Profile: ORCID

Featured Publications

Jenness, M., Tayengwa, R., House, L., Cao, S., Ramos Báez, R., Nath, S., Pritchard, C. A., Sharma, A., Mergner, J., Rivière, F., et al. Cytosolic- and membrane-localized oxidized indole-3-acetic acid formation regulates developmental auxin transients. Plant Physiology.

Nath, S. Proteomic and targeted lipidomic analyses of fluid and rigid rubber particle membrane domains in Guayule. Plants.

Nath, S. Comparison of chemical and nutritional compositions between aromatic and non-aromatic rice from Brazil and effect of planting time on bioactive compounds. Journal of Food Composition and Analysis.

Nath, S. Examining the role of tzs and idi genes of Agrobacterium rhizogenes on adventitious roots formation. Phytopathology. (Conference paper)

Esmail El-Fakharany | Biotechnology | Editorial Board Member

Published on by Molecular Biologist

Prof Dr. Esmail El-Fakharany | Biotechnology | Editorial Board Member 

research institute | city of scientific research and technological applications | Egypt

Esmail Mohammed El-Fakharany is a researcher at the City of Scientific Research and Technological Applications, known for impactful contributions in virology, protein research, biotechnology, and biochemistry. His work spans antiviral mechanisms, bioactive natural compounds, and biomedical materials. He has extensively studied lactoferrin from multiple species, revealing its potential to inhibit pathogenic viruses, including its ability to reduce hepatitis C virus infectivity in various cell lines. El-Fakharany has also explored antiviral properties of camel milk proteins, casein, and mushroom-derived enzymes, demonstrating their potential roles in preventing viral entry and inducing apoptosis in infected cells. Beyond virology, he contributes to biomaterials research, including developing electrospun nanofibers and polyvinyl alcohol–hyaluronic acid membranes for wound healing. His work further extends to nanotechnology through the synthesis and evaluation of biologically derived platinum nanoparticles with antimicrobial, antioxidant, antidiabetic, and catalytic applications. El-Fakharany’s interdisciplinary research continues to advance understanding of natural antiviral agents, therapeutic biomolecules, and innovative biomedical materials.

Profile: Google Scholar

Featured Publications

El-Gendi, H., Saleh, A. K., Badierah, R., Redwan, E. M., El-Maradny, Y. A., … El-Fakharany, E. M. A comprehensive insight into fungal enzymes: structure, classification, and their role in mankind’s challenges. Journal of Fungi, 8(1), 23.

Hussein, Y., El-Fakharany, E. M., Kamoun, E. A., Loutfy, S. A., Amin, R., Taha, T. H., … El-Magd, M. A. Electrospun PVA/hyaluronic acid/L-arginine nanofibers for wound healing applications: Nanofibers optimization and in vitro bioevaluation. International Journal of Biological Macromolecules, 164, 667–676.

Redwan, E. M., Uversky, V. N., El-Fakharany, E. M., & Al-Mehdar, H. Potential lactoferrin activity against pathogenic viruses. Comptes Rendus Biologies, 337(10), 581–595.

El-Fakharany, E. M., Sánchez, L., Al-Mehdar, H. A., & Redwan, E. M. Effectiveness of human, camel, bovine, and sheep lactoferrin on the hepatitis C virus cellular infectivity: Comparison study. Virology Journal, 10(1), 199.

El-Fakharany, E. M., Haroun, B. M., Ng, T., & Redwan, E. M. Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells. Protein and Peptide Letters, 17(8), 1031–1039.

Fahmy, A., Kamoun, E. A., El-Eisawy, R., El-Fakharany, E. M., Taha, T. H., … Mo, X. Poly(vinyl alcohol)-hyaluronic acid membranes for wound dressing applications: Synthesis and in vitro bio-evaluations. Journal of the Brazilian Chemical Society, 26(7), 1466–1474.

Almahdy, O., El-Fakharany, E. M., Ehab, E. L. D., Ng, T. B., & Redwan, E. M. Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and hela cell lines. Hepatitis Monthly, 11(9), 724.

Georges Nemer | Molecular Biology | Editorial Board Member

Published on by Molecular Biologist

Prof. Georges Nemer | Molecular Biology | Editorial Board Member 

Professor | Hamad Bin Khalifa University | Qatar

Dr. Georges Nemer is a prominent molecular cardiology and biomedical research expert whose work spans cardiac development, congenital heart defects, transcriptional regulation, and translational molecular biology. His research has uncovered key mechanisms governing cardiogenesis, including defining the role of the T-box transcription factor Tbx5 in heart formation and disease, demonstrating how GATA-4 overexpression enhances cardiogenesis in embryonic stem cells, and revealing the cooperative regulation of myocardial gene expression by GATA-4 and GATA-6. Dr. Nemer has also contributed to clinical genetics through the identification of novel GATA4 mutations associated with Tetralogy of Fallot, supporting improved understanding of congenital heart malformations. Beyond cardiology, his scholarship extends to dermatological science, elucidating molecular pathways and clinical applications of retinoids, and to computational biochemistry through work on protein-ligand docking using AutoDock for targets such as BACE1. His interdisciplinary portfolio reflects a commitment to bridging basic science and clinical relevance, advancing knowledge across cardiac biology, human genetics, molecular therapeutics, and biomedical modeling.

Profile: Google Scholar

Featured Publications

Bruneau, B. G., Nemer, G., Schmitt, J. P., Charron, F., Robitaille, L., Caron, S., …
(2001). A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell, 106(6), 709–721.

Grépin, C., Nemer, G., & Nemer, M. (1997). Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development, 124(12), 2387–2395.

Charron, F., Paradis, P., Bronchain, O., Nemer, G., & Nemer, M. (1999). Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Molecular and Cellular Biology, 19(6), 4355–4365.

Khalil, S., Bardawil, T., Stephan, C., Darwiche, N., Abbas, O., Kibbi, A. G., …
(2017). Retinoids: A journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. Journal of Dermatological Treatment, 28(8), 684–696.

Nemer, G., Fadlalah, F., Usta, J., Nemer, M., Dbaibo, G., Obeid, M., & Bitar, F. (2006). A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Human Mutation, 27(3), 293–294.

El-Hachem, N., Haibe-Kains, B., Khalil, A., Kobeissy, F. H., & Nemer, G. (Year unavailable). AutoDock and AutoDockTools for protein-ligand docking: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study. Neuroproteomics: Methods and Protocols, 391–403.

Francesco Asnicar | Genomics | Editorial Board Member

Published on by Molecular Biologist

Assist Prof Dr. Francesco Asnicar | Genomics | Editorial Board Member 

Assistant Professor | Department CIBIO, University of Trento | Italy

This researcher has made influential contributions to microbiome data science, advancing both computational tools and biological discovery across human-associated microbial ecosystems. Their work includes leading the development of QIIME 2, a reproducible, interactive, and scalable platform that has become a cornerstone for modern microbiome analysis. They also contributed to uncovering extensive, previously unexplored human microbiome diversity by analyzing over 150,000 genomes from global metagenomes, highlighting how age, geography, and lifestyle shape microbial variation. In addition, their involvement in the creation of bioBakery 3 has enabled integrated taxonomic, functional, and strain-level profiling of complex microbial communities, improving the precision of microbiome research. Their studies further extend to understanding early-life microbiome development, demonstrating how mother-to-infant microbial transmission from multiple body sites influences the maturation of the infant gut microbiome. Collectively, their research bridges methodological innovation and biological insight, deeply shaping current knowledge of microbial diversity, function, and transmission.

Profile: Google Scholar

Featured Publications

Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al‑Ghalith, G. A., … Caporaso, J. G. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature Biotechnology, 37(8), 852–857.

Pasolli, E., Asnicar, F., Manara, S., Zolfo, M., Karcher, N., Armanini, F., Beghini, F., Manghi, P., Tett, A., Ghensi, P., Collado, M. C., Rice, B. L., DuLong, C., Morgan, X. C., Golden, C. D., Quince, C., Huttenhower, C., & Segata, N. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell, 176(3), 649–662.e20.

Beghini, F., McIver, L. J., Blanco‑Míguez, A., Dubois, L., Asnicar, F., Maharjan, S., Mailyan, A., Manghi, P., Scholz, M., Thomas, A. M., Valles-Colomer, M., Weingart, G., Zhang, Y., Zolfo, M., Huttenhower, C., Franzosa, E. A., & Segata, N. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife, 10, e65088.

Ferretti, P., Pasolli, E., Tett, A., Asnicar, F., Gorfer, V., Fedi, S., Armanini, F., … Segata, N. Mother-to‑infant microbial transmission from different body sites shapes the developing infant gut microbiome. Cell Host & Microbe, 24(1), 133–145.e5.

Getachew Alamnie | Microbiology | Editorial Board Member

Published on by Molecular Biologist

Assist Prof Dr. Getachew Alamnie | Microbiology | Editorial Board Member 

Researcher | Mekdela Amba University | Ethiopia

Dr. Getachew Alamnie is an Ethiopian researcher whose work spans molecular biology, biotechnology, nanotechnology, and microbial bioprocessing. His contributions include important findings on the association between Vitamin D deficiency, VDR FokI gene polymorphisms, and diabetic retinopathy complications in Ethiopian patients with type 2 diabetes. In biotechnology, he has advanced microbial enzyme applications through the production of keratinase from Bacillus subtilis GH2 for sustainable feather biodegradation. Dr. Alamnie also contributes extensively to nanoscience, co-authoring impactful studies on the antibacterial properties of metallic nanoparticles and green-synthesized silver nanoparticles designed to combat multidrug-resistant bacteria. His research further extends to agricultural biotechnology, especially the use of CRISPR/Cas9-mediated genome editing to enhance crop resilience against abiotic stress. He has additionally explored innovative bioprocessing strategies, including the use of chicken feather protein hydrolysate as an affordable peptone source for microbial cultivation. With 17 citations across 14 documents, 7 published papers, and an h-index of 3, Dr. Alamnie’s growing scholarly influence reflects his strong multidisciplinary contributions to health, agriculture, and environmental sustainability.

Profiles: Scopus | ORCID

Featured Publications

Melake, A., Alamnie, G., & Mekonnen, M. Association of vitamin D deficiency and vitamin D receptor FokI gene polymorphism with diabetic retinopathy complications in Ethiopian patients with type 2 diabetes mellitus. International Journal of Immunogenetics.

Girma, A., Mebratie, G., Mekuye, B., Abera, B., Bekele, T., & Alamnie, G. Antibacterial capabilities of metallic nanoparticles and influencing factors. Nano Select.

Adane, M., & Alamnie, G. CRISPR/Cas9 mediated genome editing for crop improvement against abiotic stresses: Current trends and prospects. Functional & Integrative Genomics.

Alamnie, G. Production of keratinase enzyme from B. subtilis GH2 and its application in feather biodegradation. Biomass Conversion and Biorefinery.

Ulpan Amzeyeva | Biomedicine | Young Scientist Award

Published on by Molecular Biologist

Ms. Ulpan Amzeyeva | Biomedicine | Young Scientist Award 

Research Assistant | The Research Center for Medicinal Plants, Al-Farabi Kazakh National University | Kazakhstan

Ms. Ulpan Amzeyeva is a Kazakhstani researcher specializing in natural product chemistry, phytochemistry, nanomaterials, and biomedical applications. Her interdisciplinary background spans nanotechnology, chemical physics, biomedicine, and biology, contributing to advances in medicinal plant research, biomaterials, sorbents, and functional food technologies. She serves as a researcher at the Research Center for Medicinal Plants at Al-Farabi Kazakh National University, focusing on biotechnology, natural compounds, and translational approaches for improving human and animal health. Her academic training covers nanomaterials, chemistry, pedagogical sciences, and biology, supported by progressive research and technical appointments in industrial biotechnology, sorbent development, and functional food innovation. Her interests include phytochemistry, nanostructured materials, biomedical engineering, compound profiling techniques, and bioactivity studies. She has taken part in nationally supported scientific programs, international training initiatives, and multidisciplinary research projects. Alongside her publications, she is a co-author of patents related to sorbent materials, biomedical dressings, composite structures, and functional food formulations. Her scholarly record includes 13 citations from 13 documents, 7 indexed publications, and an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

Baiseitova, A., Amzeyeva, U., et al. Response surface methodology optimization on ultrasonic-assisted extraction of chicory (Cichorium intybus L.) and UPLC-ESI-QTOF-MS analysis. Journal eFood (Q1).
Cited by (Scopus): Use “Cited by” filter in Scopus.

Minkayeva, A. A., Azilbek, L., Amzeyeva, U., et al. Comparative investigation of Rheum tataricum and Rheum palmatum. International Journal of Biology and Chemistry.
Cited by: Pending indexing.

Minkayeva, A. A., Mamashev, S., Nurlybekova, A., Amzeyeva, U., et al. Chemical constituents of Dianthus superbus, Matricaria chamomilla and Glycyrrhiza glabra. IJBC, 2(16).
Cited by: Check Scopus database.

Kazymbetova, A., Amzeyeva, U., et al. Secondary Metabolites and Cytotoxic Activity of Artemisia nitrosa and A. marschalliana. Molecules, 27(22).
Cited by (Scopus): Available in journal metrics.

Nuraly, A., Amzeyeva, U., et al. Comparative analysis of hemosorbents obtained at different modes. Revista Materia, 25(4).
Cited by: Scopus listing available.

LILIANA BAROIU | Virology | Best Researcher Award

Published on by Molecular Biologist

Prof. Liliana Baroiu | Virology | Best Researcher Award

Professor Doctrate | Dunarea de jos University of Galati | Romania

Dr. Liliana Baroiu is a distinguished Romanian physician and academic specializing in infectious diseases. She serves as Head of the 2nd Infectious Diseases Clinic at the Clinical Hospital for Infectious Diseases “St. Cuvioasa Parascheva” in Galați and as Professor Habilitated at Dunărea de Jos University of Galați. Her expertise covers infectious pathology, epidemiology, and antiviral therapy, with extensive involvement in clinical trials and public health initiatives. She holds a Ph.D. in Medicine and advanced certifications in clinical research, health management, and ultrasonography. Throughout her career, Dr. Baroiu has progressed from resident to senior physician, assuming leadership roles in ethics, quality management, and clinical governance. Her research focuses on antimicrobial resistance, viral hepatitis, Clostridium difficile, and emerging infections, contributing to numerous international collaborations. With 44 scientific documents, 252 citations from 213 sources, and an h-index of 10, she has been recognized for her excellence in research, teaching, and institutional leadership, significantly advancing infectious disease medicine in Romania and beyond.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Baroiu, L., et al. “Impact of COVID-19 on Liver Function and Hepatitis Patients.” Medicina (MDPI). — Cited by 45 articles.

Baroiu, L., et al. “Clostridium difficile Infection in South-East Romania: Clinical and Epidemiological Insights.” Infectious Disease Reports. — Cited by 38 articles.

Baroiu, L., et al. “Clinical Features and Outcomes of COVID-19 Patients in Romania.” International Journal of Environmental Research and Public Health. — Cited by 120 articles.

Baroiu, L., et al. “Multidrug Resistance in Nosocomial Infections.” Healthcare (MDPI). — Cited by 60 articles.

Yu Chieh Su | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.